● Recruiting

A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis

Condition: NASH With Fibrosis · MASH With Fibrosis · Sponsor: Akero Therapeutics, Inc

PhasePhase 3

Planned participants1650

Who can joinAll sexes, 18 Years to 80 Years

Healthy volunteersNo

About this study

This is a multi-center evaluation of efruxifermin (EFX) in a randomized, double-blind, placebo-controlled study in subjects with non-cirrhotic NASH/MASH and fibrosis stage 2 or 3 (F2 or F3). The study will enroll subjects in two cohorts for a total samples size of 1650 subjects.

This description comes directly from the study's public registry record.

Talk to the study team

Akero Study Director · 650-487-6488 · AkeroSynchrony@akerotx.com

Always discuss trial participation with your own doctor first.

Locations (356)

Akero Clinical Study Site	Birmingham, Alabama, United States	Recruiting
Akero Clinical Study Site	Dothan, Alabama, United States	Recruiting
Akero Clinical Study Site	Chandler, Arizona, United States	Recruiting
Akero Clinical Study Site	Flagstaff, Arizona, United States	Completed
Akero Clinical Study Site	Peoria, Arizona, United States	Recruiting
Akero Clinical Study Site	Tucson, Arizona, United States	Recruiting
Akero Clinical Study Site	Tucson, Arizona, United States	Recruiting
Akero Clinical Study Site	Tucson, Arizona, United States	Recruiting
Akero Clinical Study Site	Tucson, Arizona, United States	Recruiting
Akero Clinical Study Site	Conway, Arkansas, United States	Completed
Akero Clinical Study Site	Jonesboro, Arkansas, United States	Completed
Akero Clinical Study Site	Little Rock, Arkansas, United States	Recruiting

+ 344 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06215716